AZZ vs EXAS · P/E 14, rev $1.58B vs rev $2.76B
AZZ Incorporated (AZZ) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
AZZ Incorporated (AZZ) is a specialty business services company listed on NYSE.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported AZZ revenue for 2025-02-28 was $1.58B. Net income was $128.8M. Revenue was up 2.6% from 2024-02-29 to 2025-02-28. AZZ currently screens at market cap $4.56B and trailing P/E 14.5.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
AZZ currently screens at market cap $4.56B and trailing P/E 14.5. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the AZZ and EXAS stock pages for the full models.
Not investment advice.